Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cimetidine as an organic cation transporter antagonist.

Literature DB >> 20651231

Cimetidine as an organic cation transporter antagonist.

Hans Ehrsson, Inger Wallin, Giuliano Ciarimboli, Eberhard Schlatter.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2010 PMID： 20651231 PMCID： PMC2928986 DOI： 10.2353/ajpath.2010.100484

Source DB: PubMed Journal: Am J Pathol ISSN： 0002-9440 Impact factor: 4.307

× No keyword cloud information.

14 in total

1. Oxaliplatin degradation in the presence of important biological sulphur-containing compounds and plasma ultrafiltrate.

Authors: Elin Jerremalm; Inger Wallin; Jeffrey Yachnin; Hans Ehrsson
Journal: Eur J Pharm Sci Date: 2006-04-18 Impact factor: 4.384

2. Reactions of cisplatin hydrolytes with methionine, cysteine, and plasma ultrafiltrate studied by a combination of HPLC and NMR techniques.

Authors: M el-Khateeb; T G Appleton; L R Gahan; B G Charles; S J Berners-Price; A M Bolton
Journal: J Inorg Biochem Date: 1999-10 Impact factor: 4.155

3. Kinetics of Cisplatin and its monohydrated complex with sulfur-containing compounds designed for local otoprotective administration.

Authors: Pernilla Videhult; Göran Laurell; Inger Wallin; Hans Ehrsson
Journal: Exp Biol Med (Maywood) Date: 2006-11

4. D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics.

Authors: Andreas Ekborn; Göran Laurell; Peter Johnström; Inger Wallin; Staffan Eksborg; Hans Ehrsson
Journal: Hear Res Date: 2002-03 Impact factor: 3.208

5. Kinetic study of the reaction of cisplatin with thiols.

Authors: James C Dabrowiak; Jerry Goodisman; Abdul-Kader Souid
Journal: Drug Metab Dispos Date: 2002-12 Impact factor: 3.922

6. Hematotoxicity and blood glutathione levels after cisplatin treatment of tumor-bearing mice.

Authors: D Khynriam; S B Prasad
Journal: Cell Biol Toxicol Date: 2001 Impact factor: 6.691

7. Molecular determinants of substrate/inhibitor binding to the human and rabbit renal organic cation transporters hOCT2 and rbOCT2.

Authors: Wendy M Suhre; Sean Ekins; Cheng Chang; Peter W Swaan; Stephen H Wright
Journal: Mol Pharmacol Date: 2005-01-03 Impact factor: 4.436

8. The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG.

Authors: Miranda Verschraagen; Marc A Kedde; Frederick H Hausheer; Wim J F Van Der Vijgh
Journal: Cancer Chemother Pharmacol Date: 2003-04-25 Impact factor: 3.333

Cimetidine as an organic cation transporter antagonist.

1. Oxaliplatin degradation in the presence of important biological sulphur-containing compounds and plasma ultrafiltrate.

2. Reactions of cisplatin hydrolytes with methionine, cysteine, and plasma ultrafiltrate studied by a combination of HPLC and NMR techniques.

3. Kinetics of Cisplatin and its monohydrated complex with sulfur-containing compounds designed for local otoprotective administration.

4. D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics.

5. Kinetic study of the reaction of cisplatin with thiols.

6. Hematotoxicity and blood glutathione levels after cisplatin treatment of tumor-bearing mice.

7. Molecular determinants of substrate/inhibitor binding to the human and rabbit renal organic cation transporters hOCT2 and rbOCT2.

8. The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG.

9. Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig.

10. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase.

1. Zwitterionic near infrared fluorescent agents for noninvasive real-time transcutaneous assessment of kidney function.

2. Drugs Commonly Applied to Kidney Patients May Compromise Renal Tubular Uremic Toxins Excretion.